Lv11
40 积分 2023-07-06 加入
Oral iptacopan monotherapy in paroxysmal nocturnal haemoglobinuria: final 48-week results from the open-label, randomised, phase 3 APPLY-PNH trial in anti-C5-treated patients and the open-label, single-arm, phase 3 APPOINT-PNH trial in patients previously untreated with complement inhibitors
11小时前
待确认
CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus
14天前
已完结
Botulinum toxin type A injection in the treatment of lichen simplex: an open pilot study
1个月前
已完结
Once-Weekly Mazdutide in Chinese Adults with Obesity or Overweight
3个月前
已完结
New Approaches to the Immunotherapy of Cancer Based on the Systemic Administration of Lymphokine-Activated Killer Cells and Recombinant Interleukin-2
3个月前
已关闭
Burden of melanoma in China, 1990–2017: Findings from the 2017 global burden of disease study
3个月前
已完结
Efficacy and safety of tezepelumab versus placebo in adults with moderate to very severe chronic obstructive pulmonary disease (COURSE): a randomised, placebo-controlled, phase 2a trial
3个月前
已关闭
Faculty Opinions recommendation of The Identification and Pharmacological Characterization of 6-(tert-Butylsulfonyl)-N-(5-fluoro-1H-indazol-3-yl)quinolin-4-amine (GSK583), a Highly Potent and Selective Inhibitor of RIP2 Kinase
5个月前
已关闭
Nemolizumab with concomitant topical therapy in adolescents and adults with moderate-to-severe atopic dermatitis (ARCADIA 1 and ARCADIA 2): results from two replicate, double-blind, randomised controlled phase 3 trials
7个月前
已完结
Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial
8个月前
已完结
皖公网安备34019202002308
